These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17111435)

  • 41. Detection, quantification, and glycotyping of prion protein in specifically activated enzyme-linked immunosorbent assay plates.
    Triantaphyllidou IE; Sklaviadis T; Vynios DH
    Anal Biochem; 2006 Dec; 359(2):176-82. PubMed ID: 17092479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity.
    Peretz D; Williamson RA; Kaneko K; Vergara J; Leclerc E; Schmitt-Ulms G; Mehlhorn IR; Legname G; Wormald MR; Rudd PM; Dwek RA; Burton DR; Prusiner SB
    Nature; 2001 Aug; 412(6848):739-43. PubMed ID: 11507642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Elusive function of prion protein].
    Hachiya NS; Kaneko K
    Nihon Rinsho; 2007 Aug; 65(8):1385-90. PubMed ID: 17695273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding of N- and C-terminal anti-prion protein antibodies generates distinct phenotypes of cellular prion proteins (PrPC) obtained from human, sheep, cattle and mouse.
    Kuczius T; Grassi J; Karch H; Groschup MH
    FEBS J; 2007 Mar; 274(6):1492-502. PubMed ID: 17302739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroglobin and prion cellular localization: investigation of a potential interaction.
    Lechauve C; Rezaei H; Celier C; Kiger L; Corral-Debrinski M; Noinville S; Chauvierre C; Hamdane D; Pato C; Marden MC
    J Mol Biol; 2009 May; 388(5):968-77. PubMed ID: 19327369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methionine sulfoxides on PrPSc: a prion-specific covalent signature.
    Canello T; Engelstein R; Moshel O; Xanthopoulos K; Juanes ME; Langeveld J; Sklaviadis T; Gasset M; Gabizon R
    Biochemistry; 2008 Aug; 47(34):8866-73. PubMed ID: 18680312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered prion protein glycosylation in the aging mouse brain.
    Goh AX; Li C; Sy MS; Wong BS
    J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent developments in prion immunotherapy.
    Heppner FL; Aguzzi A
    Curr Opin Immunol; 2004 Oct; 16(5):594-8. PubMed ID: 15342005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hot spots in prion protein for pathogenic conversion.
    Kuwata K; Nishida N; Matsumoto T; Kamatari YO; Hosokawa-Muto J; Kodama K; Nakamura HK; Kimura K; Kawasaki M; Takakura Y; Shirabe S; Takata J; Kataoka Y; Katamine S
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):11921-6. PubMed ID: 17616582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular prion protein signaling in serotonergic neuronal cells.
    Mouillet-Richard S; Schneider B; Pradines E; Pietri M; Ermonval M; Grassi J; Richards JG; Mutel V; Launay JM; Kellermann O
    Ann N Y Acad Sci; 2007 Jan; 1096():106-19. PubMed ID: 17405922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro.
    Dong CF; Wang XF; Wang X; Shi S; Wang GR; Shan B; An R; Li XL; Zhang BY; Han J; Dong XP
    Med Microbiol Immunol; 2008 Dec; 197(4):361-8. PubMed ID: 18087720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profiling the culprit in Alzheimer's disease (AD): bacterial toxic proteins - Will they be significant for the aetio-pathogenesis of AD and the transmissible spongiform encephalopathies?
    Schmitt HP
    Med Hypotheses; 2007; 69(3):596-609. PubMed ID: 17337124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurotoxic species in prion disease: a role for PrP isoforms?
    Harrison CF; Barnham KJ; Hill AF
    J Neurochem; 2007 Dec; 103(5):1709-20. PubMed ID: 17944867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases.
    Zuber C; Knackmuss S; Rey C; Reusch U; Röttgen P; Fröhlich T; Arnold GJ; Pace C; Mitteregger G; Kretzschmar HA; Little M; Weiss S
    Mol Immunol; 2008 Jan; 45(1):144-51. PubMed ID: 17576014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for prion protein expression in enteroglial cells of the myenteric plexus of mouse intestine.
    Albanese V; Lawson VA; Hill AF; Cappai R; Di Guardo G; Staikopoulos V; Thacker M; Furness JB; Chiocchetti R
    Auton Neurosci; 2008 Jun; 140(1-2):17-23. PubMed ID: 18358791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterogeneous PrPC metabolism in skeletal muscle cells.
    Massimino ML; Ferrari J; Sorgato MC; Bertoli A
    FEBS Lett; 2006 Feb; 580(3):878-84. PubMed ID: 16430889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro.
    Nishina KA; Deleault NR; Mahal SP; Baskakov I; Luhrs T; Riek R; Supattapone S
    Biochemistry; 2006 Nov; 45(47):14129-39. PubMed ID: 17115708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biomedicine. A view from the top--prion diseases from 10,000 feet.
    Priola SA; Chesebro B; Caughey B
    Science; 2003 May; 300(5621):917-9. PubMed ID: 12738843
    [No Abstract]   [Full Text] [Related]  

  • 60. Trace elements and prion diseases: a review of the interactions of copper, manganese and zinc with the prion protein.
    Leach SP; Salman MD; Hamar D
    Anim Health Res Rev; 2006; 7(1-2):97-105. PubMed ID: 17389057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.